IP Library Granted Patent US 7,238,834
Granted Patent B2
US 7,238,834 · App. 11/250,924 · Granted Jul 3, 2007

Piperidine derivatives and process for their production

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,238,834
App. No.
11/250,924
Granted
Jul 3, 2007
Kind
B2
Abstract

The present invention relates to substantially pure piperidine derivative compounds of the formulae: wherein R 1 is hydrogen or hydroxy; R 2 is hydrogen; or R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 ; R 3 is —COOH or —COOR 4 ; R 4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents. A process of preparing such piperidine derivative compounds in substantially pure form is also disclosed.

Claims (89)

1. A process of preparing a substantially pure regioisomer of the formula:

wherein

R 3 is —COOR 4 ;

R 4 is chosen from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, 5 carbon alkyl, and 6 carbon alkyl;

A is a substituent of its ring selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy,

said process comprising:

providing a mixture of regioisomers of the formula:

recovering from the mixture of regioisomers the substantially pure regioisomer of the formula:

esterifying the substantially pure regioisomer to yield:

2. A process according to claim 1 , wherein said providing the mixture of regiolsomers comprises:

acylating a starting compound of the formula:

 wherein

R 5 is —OR 6 , —N(R 6 ) 2 , and —SR 6 , and

R 6 is an alkyl with 1 to 6 carbons,

with a compound of the formula:

wherein

X is a halogen,

under conditions effective to produce a mixture of regioisomers of the formula:

hydrolyzing the first mixture of regioisomers under conditions effective to form the second mixture of regioisomers of the formula:

3. A process according to claim 2 , wherein said acylating is carried out by a Friedel-Crafts reaction using an AlCl 3 catalyst.

4. A process according to claim 1 , wherein said providing the mixture of regioisomers comprises:

acylating a starting compound of the formula:

 wherein

R 5 is —OR 6 , —N(R 6 ) 2 , and —SR 6 , and

R 6 is an alkyl with 1 to 6 carbon atoms,

with a compound of the formula:

under conditions effective to produce a first mixture of regioisomers of the formula:

hydrolyzing the first mixture of regioisomers under conditions effective to form a second mixture of regioisomers of the formula:

5. A process according to claim 1 , wherein said recovering comprises:

crystallizing from the second mixture of regioisomers a substantially pure regioisomer salt of the formula:

 wherein X + is a Lewis acid;

isolating the substantially pure regioisomer salt; and

converting the substantially pure regioisomer salt to the substantially pure regioisomer of the formula:

6. A process according to claim 5 , wherein X + is an alkali metal salt or an ammonium salt of the form NR 7 , R 8 , R 9 wherein R 7 , R 8 , and R 9 are individually hydrogen or a straight or branched alkyl of 1 to 6 carbon atoms, or an alkyl substituted at any position with a phenyl ring or a substituted phenyl ring.

7. A process according to claim 6 , wherein X + is cinchonidine and A is hydrogen.

8. A process of preparing a substantially pure regioisomer of the formula:

wherein

R 3 is —COOR 4 ;

R 4 is chosen from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, 5 carbon alkyl, and 6 carbon alkyl;

A is a substituent of its ring selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy,

said process comprising:

acylating a starting compound of the formula:

 wherein

R 5 is OR 6 , —N(R 6 ) 2 , and —SR 6 , and

R 6 is an alkyl with 1 to 6 carbons,

with a compound of the formula:

wherein

X is a halogen,

under conditions effective to produce a first mixture of regioisomers of the formula:

 and

converting the first mixture of regioisomers to the substantially pure regioisomer of formula:

9. A process of preparing a substantially pure regioisomer of the formula:

wherein

R 3 is —COOR 4 ;

R 4 is chosen from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, 5 carbon alkyl, and 6 carbon alkyl;

A is a substituent of its ring selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy,

said process comprising:

acylating a starting compound of the formula:

 wherein

R 5 is —OR 6 , —N(R 6 ) 2 , and —SR 6 , and

R 6 is an alkyl with 1 to 6 carbon atoms with a compound of the formula:

 under conditions effective to produce a first mixture of regioisomers of the formula:

 and

converting the first mixture of regioisomers to the substantially pure regioisomer of formula:

10. A process of preparing a substantially pure regioisomer of the formula:

wherein

R 3 is —COOR 4 ;

R 4 is chosen from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, 5 carbon alkyl, and 6 carbon alkyl;

A is a substituent of its ring selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy,

said process comprising:

acylating a starting compound of the formula:

 with a compound of the formula:

wherein

X 1 is a halogen, trialkyl tin, triflate, or substituents useful in organometalic coupling reactions under conditions effective to produce the substantially pure regioisomer.

11. A substantially pure regioisomer having the formula:

wherein

X is a halogen;

R 3 is —COOR 4 ;

R 4 is chosen from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, 5 carbon alkyl, and 6 carbon alkyl;

A is a substituent of its ring selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy.

12. A process of preparing a second substantially pure regiolsomer of the formula:

wherein

X is a halogen;

R 3 is —COOR 4 ;

R 4 is chosen from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, 5 carbon alkyl, and 6 carbon alkyl;

A is a substituent of its ring selected from the group consisting of hydrogen, halogens, alkyl, hydroxy or alkoxy,

said process comprising:

providing a first substantially pure regioisomer of the formula:

halogenating the first substantially pure regioisomer under conditions effective to form the second substantially pure regioisomer.

Assignments (10)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 7541537 PREVIOUSLY RECORDED AT REEL: 034045 FRAME: 0951. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Aug 14, 2018
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 046796/0352 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC; AMRI SSCI, LLC; EUTICALS INC.
Reel/Frame 043742/0085 →
SECURITY INTEREST Recorded Oct 24, 2014
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 034045/0951 →
RELEASE OF SECURITY INTEREST Recorded Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
SECURITY AGREEMENT Recorded Apr 20, 2012
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI RENESSELAER, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 028078/0227 →
TERMINATION Recorded Apr 19, 2012
From: BANK OF AMERICA, N.A.
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI BURLINGTON, INC.; AMRI RENESSELAER, INC.
Reel/Frame 028072/0335 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 6, 2011
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI RENSSELAER, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI BURLINGTON, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026397/0001 →
MERGER Recorded Feb 8, 2010
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 023905/0317 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2009
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 022092/0512 →
LICENSE Recorded Dec 12, 2006
From: AMR TECHNOLOGY, INC. (F.K.A. ALBANY MOLECULAR RESEARCH INC.)
To: AVENTIS PHARMACEUTICALS INC. (F.K.A. MARION MERRELL DOW INC.)
Reel/Frame 018616/0373 →